Status:
COMPLETED
Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Schering-Plough
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
We hypothesize that those patients with purely seasonal allergic rhinitis will decongest better than those subjects with another cause contributing to their symptoms. These latter patients will not im...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Males and females between 18 and 60 years of age.
- History of grass and/or ragweed allergic rhinitis.
- Positive skin or RAST test to grass, trees and/or ragweed antigen.
- Symptomatic at time of entry into study.
- Exclusion Criteria
- Women of childbearing potential not using the contraception method(s) (Birth control pills, depo Provera, double barrier) as well as women who are pregnant or breastfeeding.
- Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study (heart, lung, kidney, neurological, oncologic or liver disease).
- Use of any other investigational agent in the last 30 days.
- Absence of nasal symptoms.
- Smoking.
- URI at the time of screening.
Exclusion
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00618332
Start Date
April 1 2008
End Date
July 1 2010
Last Update
February 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637